Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Phillips

Showing results (131-140 of 286) with videos related to

Pageof 29
Sort By:
Public Health|December 15, 2006
The increasing prevalence of diabetes in South Australia: the relationship with population ageing and obesityC R Chittleborough, J F Grant, P J Phillips, et al.
The Journal of Infectious Diseases|November 24, 2012
Reply to Dodd and ProschanPatrick P J Phillips, Daniel J Bratton, Andrew J Nunn, et al.
Bone & Joint Research|April 24, 2013
Osteoporosis in the community: Sensitivity of self-reported estimates and medication use of those diagnosed with the conditionT K Gill, A W Taylor, C L Hill, et al.
The Biochemical Journal|August 15, 1997
Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phaseJ D Weber, D M Raben, P J Phillips, et al.
The Medical Journal of Australia|November 3, 1979
A simple screening strategy for diagnosing the porphyriasR W Pain, P J Phillips, H A Harley, et al.
Australian and New Zealand Journal of Medicine|December 1, 1980
Rifampicin associated renal dysfunction during antituberculous therapyA G Need, P J Phillips, F T Chiu, et al.
Lancet (London, England)|May 15, 1982
Diphosphonates for periarticular ossificationA G Need, K A Angel, B L Cornish, et al.
The Medical Journal of Australia|May 21, 1977
Alcohol, blood and Dextrostix do not mixP J Phillips, R W Pain, L B To, et al.
Breathe (Sheffield, England)|October 13, 2023
Treatment-shortening regimens for tuberculosis: updates and future prioritiesFrancesca Saluzzo, Victor Abiola Adepoju, Raquel Duarte, et al.
The Lancet. Infectious Diseases|November 29, 2024
Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic reviewWilliam Burman, Pauline Luczynski, C Robert Horsburgh, et al.
Pageof 29

Showing results (131-140 of 286) with videos related to

Sort By:
Pageof 29
Public Health|December 15, 2006
The increasing prevalence of diabetes in South Australia: the relationship with population ageing and obesityC R Chittleborough, J F Grant, P J Phillips, et al.
The Journal of Infectious Diseases|November 24, 2012
Reply to Dodd and ProschanPatrick P J Phillips, Daniel J Bratton, Andrew J Nunn, et al.
Bone & Joint Research|April 24, 2013
Osteoporosis in the community: Sensitivity of self-reported estimates and medication use of those diagnosed with the conditionT K Gill, A W Taylor, C L Hill, et al.
The Biochemical Journal|August 15, 1997
Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phaseJ D Weber, D M Raben, P J Phillips, et al.
The Medical Journal of Australia|November 3, 1979
A simple screening strategy for diagnosing the porphyriasR W Pain, P J Phillips, H A Harley, et al.
Australian and New Zealand Journal of Medicine|December 1, 1980
Rifampicin associated renal dysfunction during antituberculous therapyA G Need, P J Phillips, F T Chiu, et al.
Lancet (London, England)|May 15, 1982
Diphosphonates for periarticular ossificationA G Need, K A Angel, B L Cornish, et al.
The Medical Journal of Australia|May 21, 1977
Alcohol, blood and Dextrostix do not mixP J Phillips, R W Pain, L B To, et al.
Breathe (Sheffield, England)|October 13, 2023
Treatment-shortening regimens for tuberculosis: updates and future prioritiesFrancesca Saluzzo, Victor Abiola Adepoju, Raquel Duarte, et al.
The Lancet. Infectious Diseases|November 29, 2024
Representativeness and adverse event reporting in late-phase clinical trials for rifampin-susceptible tuberculosis: a systematic reviewWilliam Burman, Pauline Luczynski, C Robert Horsburgh, et al.
Pageof 29